New color-based (chromogenic) culture media to help detect Candida infections faster
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare settings*
iFAST ONE reduces antimicrobial susceptibility test time to under 3 hours
This partnership aims to enable faster, more reliable respiratory testing outside traditional lab settings without the need for instruments or extended sample preparation
Dr. Nathan Ledeboer highlights how new antimicrobial combos and accurate susceptibility testing are helping fight against AMR
Reimagining clinical microbiology with key technologies and long-acting therapies
New compact analyzer combines 5-part extended DIFF with rapid CRP whole blood measurement, delivering clinically relevant information for enhanced diagnoses in laboratory settings
President of Diagnostic Solutions at Hologic explains how adopting advanced molecular‑diagnostic technologies is for labs of the future
Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
Dr. Manu De Rycker, a Principal Investigator at the University of Dundee, has been named as the newest winner of the WH Pierce Global Impact in Microbiology Prize
Guest editorial by Kerstin Wagner, Co-CEO & COO, United Robotics Group
The kit as broad coverage for influenza strains, emerging SARS-CoV-2 variants, and detection of both RSV subgroups A and B
In this guest editorial discover what remains in our arsenal to combat antibiotic resistance, and how HORIBA Medical is advancing responsible prescribing to protect patient outcomes
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
Guest editorial by Susan Dawson, retired laboratory leader and founder of Accomplish More Consulting Services (AMCS)
The system’s unique technology utilizes microfluidics and live imaging to monitor bacterial growth across a linear antibiotic gradient
In this guest blog, discover why verifying new testing systems is essential for ensuring accuracy and reproducibility when introducing innovative methods into your lab
Explore the shifting landscape of antimicrobial resistance and Group B Streptococcus in this expert-led guest blog
New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care
Championing biomedical science, combating antimicrobial resistance, and inspiring future generations in Africa
New proof-of-concept study of a direct-from-blood application to accelerate sepsis diagnostic workflows
Learn why the clinical lab plays an important role in antibiotic stewardship programs and sepsis care in this cross-departmental discussion between pharmacy, lab, and critical patient care providers
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship